Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Depression
NCT07239011Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in major depressive disorder (MDD), sponsored by Tanta University. Started Nov 2025; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07239011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07239011.